Longboard Pharmaceuticals... (LBPH)
59.98
0.00 (0.00%)
At close: Nov 29, 2024, 6:00 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 |
| Net Income | -54.42M | -43.95M | -27.80M | -14.40M |
| Depreciation & Amortization | 5.00K | 5.00K | 1K | n/a |
| Stock-Based Compensation | 3.25M | 2.66M | 1.97M | 8.51M |
| Other Working Capital | 1.57M | 2.84M | 1.15M | 1.24M |
| Other Non-Cash Items | -972.00K | 101.00K | 157.00K | 7.29M |
| Deferred Income Tax | n/a | n/a | n/a | n/a |
| Change in Working Capital | 1.27M | 3.12M | 967.00K | 2.45M |
| Operating Cash Flow | -50.87M | -38.06M | -24.70M | -3.44M |
| Capital Expenditures | n/a | n/a | -16.00K | n/a |
| Acquisitions | n/a | n/a | n/a | n/a |
| Purchase of Investments | -71.72M | -57.61M | -40.70M | n/a |
| Sales Maturities Of Investments | 95.95M | 40.55M | n/a | n/a |
| Other Investing Acitivies | n/a | -17.06K | -40.70K | n/a |
| Investing Cash Flow | 24.23M | -17.06M | -40.72M | n/a |
| Debt Repayment | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | -205.00K |
| Dividend Paid | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -1.60M | -444.00K | -8.32M | 58.76M |
| Financial Cash Flow | 30.19M | -444.00K | 76.45M | 58.76M |
| Net Cash Flow | 3.56M | -55.57M | 11.03M | 55.32M |
| Free Cash Flow | -50.87M | -38.06M | -24.72M | -3.44M |